Jamie Dlugosch

Jamie Dlugosch

InvestorPlace Writer

Jamie Dlugosch has over 20 years of experience in financial markets including investment banking, equity analysis and research and money management.

Previously, he was the publisher of Al Frank’s Prudent Speculator and CEO of Al Frank Investment Management Inc. He is the founder and editor of The Rational Investor.

Jamie earned his Master’s in Business Administration from the University of North Carolina. He currently lives in Minneapolis with his wife, Sarah, and their two daughters, Julia and Ellie.

Recent Articles

5 Recession-Proof Stocks to Buy Now

By Jamie Dlugosch, InvestorPlace Writer

Investors trying to time a bottom have been burned, and the reality is that we are still not out of the woods. So is it time to give up? Not at all! There are some stocks that will be reliable investments no matter how long the recession lasts. These are the five best recession-proof stocks to own now.

Illinois Tool Works (ITW) Revises Outlook, Gets Hammered

By Jamie Dlugosch, InvestorPlace Writer

Illinois Tool Works (ITW) sharply reduced their forecast of revenues and earnings for the first quarter, sending shockwaves through the market for the company's stock.

Smithfield Foods (SFD): Less Pork and Lowering Costs

By Jamie Dlugosch, InvestorPlace Writer

Smithfield Foods (SFD), the nation's largest hog producer and pork processor, said it lost 15 cents per share in the quarter ending Feb. 1, 2009, excluding a restructuring charge and other one-time items, on sales of $3.35 billion.

Men’s Warehouse (MW): Did Promotions Do the Trick?

By Jamie Dlugosch, InvestorPlace Writer

Shares of men's apparel retailer The Men's Wearhouse (MW) were one of Thursday's big winners after the company posted better-than-expected results for its fourth quarter ending Jan. 31, 2009.

Korn/Ferry (KFY): Definitely Not a Recession-Proof Stock

By Jamie Dlugosch, InvestorPlace Writer

Korn/Ferry International Inc. (KFY) in its third-quarter earnings release noted that traditional customers of executive search and staffing firms are reducing spending at an unprecedented pace.

Will Biologics and Sutent Save Pfizer (PFE)?

By Jamie Dlugosch, InvestorPlace Writer

When a drug company is facing the expiration of patent rights for a product which delivers 25% of company revenue, it has to find sources to replace the loss. This was the issue facing Lipitor maker Pfizer Inc. (PFE), the world's largest pharmaceutical company.

MGM Not So Grand, Bond Downgraded

By Jamie Dlugosch, InvestorPlace Writer

MGM Mirage (MGM) continues to reel after a spate of negative developments were announced last week. MGM saw its bonds plunge in price after a ratings cut.

5 Bank Stocks You’d Be Crazy NOT to Buy

By Jamie Dlugosch, InvestorPlace Writer

So you'd have to be crazy to own bank stocks now, right? Wrong. Here are five banks stocks that you'd be crazy NOT to buy at these levels for the long term.

High Yield Bonds: Starwood Retains Sufficient Liquidity

By Jamie Dlugosch, InvestorPlace Writer

Though still retaining investment grade status, Starwood bonds are yielding returns indicating investor concerns about the industry.

KMG Chemicals (KMGB) Primed For Recovery

By Jamie Dlugosch, InvestorPlace Writer

Despite falling sales, KMG Chemicals (KMGB) has managed to stay profitable and looks to benefit once the economy eventually recovers.

Load More